Prescription drug · ANDA
Erythromycin Ethylsuccinate NDC 24338-110
Erythromycin ethylsuccinate 400 mg/1 · Tablet · Oral · Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 24338-110-03 | 24338011003 | 30 TABLET in 1 BOTTLE (24338-110-03)Marketed from Oct 3, 2011 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Erythromycin Ethylsuccinate
- Generic name (nonproprietary)
- erythromycin ethylsuccinate
- Active ingredients
- Erythromycin ethylsuccinate — 400 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 061904
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Sebaceous Gland Activity (Physiologic effect)Macrolides (Chemical structure)
- Identifiers
- Product ID 24338-110_0ca6d238-d01f-04ea-e063-6394a90a7b84SPL ID 0ca6d238-d01f-04ea-e063-6394a90a7b84SPL set ID 23a0564e-dca9-41bc-b2c7-0461169f65f9RxCUI 686405UNII 1014KSJ86FUPC 0324338110034
- Pharmacologic class
- Macrolide Antimicrobial; Macrolide
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N424338011003followed by a unit qualifier and the quantityPackage 24338-0110-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin ethylsuccinate tablets, USP and other antibacterial drugs, erythromycin ethylsuccinate tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Erythromycin ethylsuccinate tablets, USP are indicated in the treatment of infections cau…
Excerpt only. Read the full label for complete information.